Literature DB >> 21883466

Thrombectomy of prosthetic dialysis grafts using mechanical plus "no-wait lysis" approach requires less procedure time and radiation exposure.

Ammar Almehmi1, Mike Broce, Shouwen Wang.   

Abstract

In spite of the existence of various strategies, dialysis graft thrombectomy remains time-consuming and requires substantial radiation exposure. The authors report a new approach for graft thrombectomy, "no-wait lysis", with the objective to examine its effect on procedure time and radiation exposure. Based on the use of tissue plasminogen activator (tPA), the 88 retrospectively reviewed graft thrombectomies were divided into "no-tPA" group (n = 35) and "no-wait lysis" group (n = 53). Fogarty thrombectomy and balloon angioplasty were used similarly in both groups. In the "no-wait lysis" group, small-dose tPA was added directly into the graft during the procedure. Comparing the "no-wait lysis" group with the "no-tPA" group, the procedure time was reduced: 27.2 ± 10.2 vs. 55.5 ± 19.9 minutes (p < 0.0001), and the radiation exposure time was decreased correspondingly: 159.4 ± 61.6 vs. 243.9 ± 101.9 seconds (p < 0.0001). Multivariate regression analysis revealed that the use of "no-wait lysis" approach was the major significant predictor for shorter procedure time and radiation exposure time. In conclusion, our data support that the use of "no-wait lysis" approach for dialysis graft thrombectomy substantially reduces procedure time and radiation exposure, and it may serve as an efficient and economical alternative to other existing approaches.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883466     DOI: 10.1111/j.1525-139X.2011.00922.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  1 in total

Review 1.  Endovascular Management of Thrombosed Dialysis Vascular Circuits.

Authors:  Ammar Almehmi; Mohamed Sheta; Masa Abaza; Sloan E Almehmi; Husam El-Khudari; Aisha Shaikh
Journal:  Semin Intervent Radiol       Date:  2022-02-18       Impact factor: 1.513

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.